2 research outputs found
Treatment success indicators by cohort (n = 231).
<p>CI = Confidence Interval, IQA = Internationally quality assured, IQR = Interquartile range</p><p>*Expressed as a percentage of patients who were smear-positive at treatment initiation (84 in the GLC group and 133 in the non-GLC group)</p><p>** Observations censored after 6 months (182.5 days); 66% converted by 6 months</p><p>†Data on weight gain at 6 months post treatment initiation available for 188 patients</p><p>Treatment success indicators by cohort (n = 231).</p
Patient characteristics at baseline by cohort (n = 231).
<p>IQA = Internationally quality assured; IQR = interquartile range; <i>PAS = Para aminosalicylic acid / Eto = Ethionamide / Cs = Cycloserine</i></p><p>*9 patients had no sputum smear result within 2 weeks of treatment initiation</p><p>Patient characteristics at baseline by cohort (n = 231).</p